CN100427473C - Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide - Google Patents
Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide Download PDFInfo
- Publication number
- CN100427473C CN100427473C CNB2006101547228A CN200610154722A CN100427473C CN 100427473 C CN100427473 C CN 100427473C CN B2006101547228 A CNB2006101547228 A CN B2006101547228A CN 200610154722 A CN200610154722 A CN 200610154722A CN 100427473 C CN100427473 C CN 100427473C
- Authority
- CN
- China
- Prior art keywords
- pyrazine
- bromo
- consumption
- cuprous iodide
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PMSVVUSIPKHUMT-UHFFFAOYSA-N cyanopyrazine Chemical compound N#CC1=CN=CC=N1 PMSVVUSIPKHUMT-UHFFFAOYSA-N 0.000 title claims abstract description 29
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 title description 3
- 229940079593 drug Drugs 0.000 title description 2
- 229960005206 pyrazinamide Drugs 0.000 title description 2
- 201000008827 tuberculosis Diseases 0.000 title description 2
- 238000001308 synthesis method Methods 0.000 title 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims abstract description 35
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229910021595 Copper(I) iodide Inorganic materials 0.000 claims abstract description 21
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims abstract description 21
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 16
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003054 catalyst Substances 0.000 claims abstract description 13
- 239000000706 filtrate Substances 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 9
- 150000004996 alkyl benzenes Chemical class 0.000 claims abstract description 7
- WGFCNCNTGOFBBF-UHFFFAOYSA-N 2-bromopyrazine Chemical compound BrC1=CN=CC=N1 WGFCNCNTGOFBBF-UHFFFAOYSA-N 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 15
- 235000007715 potassium iodide Nutrition 0.000 claims description 14
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 10
- 238000010189 synthetic method Methods 0.000 claims description 10
- 229940072185 drug for treatment of tuberculosis Drugs 0.000 claims description 9
- 229960004839 potassium iodide Drugs 0.000 claims description 9
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 8
- 238000005194 fractionation Methods 0.000 claims description 8
- 239000007810 chemical reaction solvent Substances 0.000 claims description 5
- 125000003944 tolyl group Chemical group 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract description 2
- 229940124976 antitubercular drug Drugs 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000000814 tuberculostatic agent Substances 0.000 abstract 1
- CAWHJQAVHZEVTJ-UHFFFAOYSA-N methylpyrazine Chemical compound CC1=CN=CC=N1 CAWHJQAVHZEVTJ-UHFFFAOYSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- GNTDGMZSJNCJKK-UHFFFAOYSA-N divanadium pentaoxide Chemical compound O=[V](=O)O[V](=O)=O GNTDGMZSJNCJKK-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910052728 basic metal Inorganic materials 0.000 description 1
- 150000003818 basic metals Chemical class 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- XDBSEZHMWGHVIL-UHFFFAOYSA-M hydroxy(dioxo)vanadium Chemical compound O[V](=O)=O XDBSEZHMWGHVIL-UHFFFAOYSA-M 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical class [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses a synthesizing method of 2-cyano pyrazine as key intermediate of antitubercular drugs aldinamide, which comprises the following steps: adopting alkyl benzene as reacting solvent; making 1.5-3% cuprous iodide, potassium iodide and 1-1.5% N, N'-dimethyldiamine as composite catalyst; reacting 2, 2-difluobromobenzene and sodium cyanide with molar rate at 1: 1.0-2.0 protected by nitrogen at 100-150 Deg C for 20-48h; filtering; decompressing the filtrate; fractioning to obtain the product. The invention shortens reacting flow path, which is simple to feed and dispose.
Description
Technical field
The present invention relates to the medicine intermediate preparation method, relate in particular to a kind of synthetic method of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine.
Background technology
The important source material of 2 cyano pyrazine production for treating tuberculosis drug pyrazinamide.Therefore how efficiently Synthetic 2-cyanopyrazine receives people's huge concern.Synthetic more existing bibliographical informations of 2 cyano pyrazine have been reported the research of special catalyst catalysis 2-methylpyrazine prepared by ammoxidation 2 cyano pyrazine such as document " fine chemistry industry ".Document Applied Catalsis, 1986, cyclization dehydration dehydrogenation under catalyst action is 2 monomethyl pyrazines to the 20:219-222 report with quadrol and propylene glycol earlier, the High Temperature High Pressure catalytic ammoxidation is 2 one cyanopyrazines again.Document CN1398855 has reported that by adopting with 2-methylpyrazine, ammonia and oxygen be raw material, in temperature of reaction is 300~500 ℃, in the gauge pressure reaction pressure is under-0.05~0.05MPa condition, and raw material is by with vanadium, chromium catalyst system and non-imposed interpolation phosphorus and be selected from basic metal or the technical scheme of the fluid catalyst bed that alkaline-earth metal is formed is used for the industrial production of 2 cyano pyrazine.Document CN1408711 has reported the catalyzer that a kind of 2-methylpyrazine Synthetic 2-cyanopyrazine uses, and this catalyzer adopts metavanadic acid ammonia, Vanadium Pentoxide in FLAKES, and ammonium molybdate, phosphoric acid are through flooding the loaded catalyst of preparation system.Document CN1429820 has reported that a kind of oxidation proceses of ammonia prepares the method and the special-purpose catalyst of 2 cyano pyrazine, it is to be Primary Catalysts with vanadium, titanium, and phosphorus, iron, nickel, cobalt, bismuth, manganese, chromium, molybdenum, copper, zinc, tin, boron, potassium, lithium, magnesium etc. are the multicomponent catalyst of promotor.Above-mentioned these synthesis technique Preparation of Catalyst complexity, reaction process is long cycle time, the condition harshness, or have many experimentations to relate to variety of problems such as high-temperature and high-pressure conditions, low-yield, aftertreatment complexity.Thereby under the condition of gentleness, the synthesis technique that solves 2 cyano pyrazine efficiently is very important and urgent.
Summary of the invention
The synthetic method that the purpose of this invention is to provide a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine.
It is to be reaction solvent with the alkylbenzene; with cuprous iodide; potassiumiodide and N; N '-dimethyl-ethylenediamine is a combination catalyst; 2-bromo-pyrazine and sodium cyanide reacted 20~48 hours at 100~150 ℃ under nitrogen protection; subsequent filtration; the filtrate decompression fractionation obtains 2 cyano pyrazine; the molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is 1: 1.0~2.0; the consumption of cuprous iodide is 5~30% molar equivalents of 2-bromo-pyrazine; the consumption of potassiumiodide is 1.5~3 molar equivalents of cuprous iodide; N, the consumption of N '-dimethyl-ethylenediamine are 1~1.5 molar equivalent of 2-bromo-pyrazine, and reaction formula is:
Described reaction solvent alkylbenzene is toluene, ethylbenzene or dimethylbenzene.
Reaction times is preferably 20~36 hours.Temperature of reaction is preferably 100~130 ℃.The molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is preferably 1: 1.0~and 1.5; The consumption of cuprous iodide is preferably 5~20% molar equivalents of 2-bromo-pyrazine; The consumption of potassiumiodide is preferably 1.5~2.5 molar equivalents of cuprous iodide; N, the consumption of N '-dimethyl-ethylenediamine are preferably 1~1.2 molar equivalent of 2-bromo-pyrazine.
The present invention compares with existing synthetic method, has the following advantages:
1) reaction conditions gentleness;
2) the reaction process flow process is short;
3) use cheap reagent;
4) feed intake and aftertreatment all very simple, be easy to realize industrialized production.
Embodiment
The molecular formula of 2 cyano pyrazine is:
The concrete reactions steps of the synthetic method of anti-tuberculosis drugs pyrazinoic acid amide key intermediate 2 cyano pyrazine is as follows:
With the alkylbenzene is reaction solvent; with cuprous iodide, potassiumiodide and N, N '-dimethyl-ethylenediamine is a combination catalyst, and 2-bromo-pyrazine and sodium cyanide reacted 20~48 hours at 100~150 ℃ under nitrogen protection; subsequent filtration, filtrate decompression fractionation obtain high yield, highly purified 2 cyano pyrazine.Wherein the molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is 1: 1.0~2.0; The consumption of cuprous iodide is 5~30% molar equivalents of 2-bromo-pyrazine; The consumption of potassiumiodide is 1.5~3 molar equivalents of cuprous iodide; N, the consumption of N '-dimethyl-ethylenediamine are 1~1.5 molar equivalent of 2-bromo-pyrazine.Recommendation response solvent alkylbenzene is toluene, ethylbenzene, dimethylbenzene, and override is a toluene.The recommendation response time is 20~36 hours, and override is 24 hours.The recommendation response temperature is 100~130 ℃, and override is 110 ℃.Recommending the molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is 1: 1.0~1.5, and override is 1: 1.2; The consumption of cuprous iodide is 5~20% molar equivalents of 2-bromo-pyrazine, and override is 10% molar equivalent; The consumption of potassiumiodide is 1.5~2.5 molar equivalents of cuprous iodide, and override is 2 molar equivalents; N, the consumption of N '-dimethyl-ethylenediamine are 1~1.2 molar equivalent of 2-bromo-pyrazine, and override is 1 molar equivalent.
Following examples will help to understand the present invention, but be not limited to content of the present invention:
Embodiment 1
In 1 liter of three-necked bottle; add 500 milliliters of toluene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines, 11.8 gram (0.36 mole, 1.2 equivalents) sodium cyanides; 5.73 gram (30 mmoles; 0.1 cuprous iodide equivalent), 10 gram potassiumiodides (60 mmoles, 0.2 equivalent); 26.4 gram N; N '-dimethyl-ethylenediamine (0.3 mole, 1.0 equivalents), under nitrogen protection 110 ℃ of stirring reactions 30 hours; finish reaction; subsequent filtration, the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 70%; purity 99% (GC), 84~87 ℃ of boiling points (18-20mmHg).
Embodiment 2
In 1 liter of three-necked bottle; add 500 milliliters of ethylbenzene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines; 11.8 gram (0.36 mole, 1.2 equivalents) sodium cyanide, 5.73 gram (30 mmoles; 0.1 cuprous iodide equivalent); 10 gram potassiumiodides (60 mmoles, 0.2 equivalent), 26.4 gram N; (0.3 mole of N '-dimethyl-ethylenediamine; 1.0 equivalent), under nitrogen protection,, finish reaction 120 ℃ of stirring reactions 25 hours; subsequent filtration; the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 73%, purity 99%.
Embodiment 3
In 1 liter of three-necked bottle; add 500 milliliters of toluene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines; 11.8 gram (0.36 mole, 1.2 equivalents) sodium cyanide, 5.73 gram (30 mmoles; 0.1 cuprous iodide equivalent); 11 gram potassiumiodides (66 mmoles, 0.22 equivalent), 26.4 gram N; (0.3 mole of N '-dimethyl-ethylenediamine; 1.0 equivalent), under nitrogen protection,, finish reaction 105 ℃ of stirring reactions 36 hours; subsequent filtration; the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 71%, purity 99%.
Embodiment 4
In 1 liter of three-necked bottle; add 500 milliliters of ethylbenzene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines; 19.8 gram (0.6 mole, 2 equivalents) sodium cyanide, 2.83 gram (15 mmoles; 0.05 cuprous iodide equivalent); 10 gram potassiumiodides (60 mmoles, 0.3 equivalent), 39 gram N; (0.45 mole of N '-dimethyl-ethylenediamine; 1.5 equivalent), under nitrogen protection,, finish reaction 130 ℃ of stirring reactions 205 hours; subsequent filtration; the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 77%, purity 99%.
Embodiment 5
In 1 liter of three-necked bottle; add 500 milliliters of dimethylbenzene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines; 11.8 gram (0.36 mole, 1.2 equivalents) sodium cyanide, 17.2 gram (90 mmoles; 0.3 cuprous iodide equivalent); 22 gram potassiumiodides (132 mmoles, 0.44 equivalent), 26.4 gram N; (0.3 mole of N '-dimethyl-ethylenediamine; 1.0 equivalent), under nitrogen protection,, finish reaction 100 ℃ of stirring reactions 48 hours; subsequent filtration; the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 72%, purity 99%.
Claims (5)
1. the synthetic method of an anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine; it is characterized in that it is is reaction solvent with the alkylbenzene; with cuprous iodide; potassiumiodide and N; N '-dimethyl amine is a combination catalyst; 2-bromo-pyrazine and sodium cyanide reacted 20~48 hours at 100~150 ℃ under nitrogen protection; subsequent filtration; the filtrate decompression fractionation obtains 2 cyano pyrazine; the molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is 1: 1.0~2.0; the consumption of cuprous iodide is 5~30% molar equivalents of 2-bromo-pyrazine; the consumption of potassiumiodide is 1.5~3 molar equivalents of cuprous iodide; N; the consumption of N '-dimethyl-ethylenediamine is 1~1.5 molar equivalent of 2-bromo-pyrazine, and reaction formula is:
2. the synthetic method of a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine according to claim 1 is characterized in that described reaction solvent alkylbenzene is toluene, ethylbenzene or dimethylbenzene.
3. the synthetic method of a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine according to claim 1 is characterized in that the described reaction times is 20~36 hours.
4. the synthetic method of a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine according to claim 1 is characterized in that described temperature of reaction is 100~130 ℃.
5. the synthetic method of a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine according to claim 1, the molar equivalent ratio that it is characterized in that described 2-bromo-pyrazine and sodium cyanide is 1: 1.0~1.5; The consumption of cuprous iodide is 5~20% molar equivalents of 2-bromo-pyrazine; The consumption of potassiumiodide is 1.5~2.5 molar equivalents of cuprous iodide; N, the consumption of N '-dimethyl-ethylenediamine are 1~1.2 molar equivalent of 2-bromo-pyrazine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101547228A CN100427473C (en) | 2006-11-21 | 2006-11-21 | Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101547228A CN100427473C (en) | 2006-11-21 | 2006-11-21 | Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1962646A CN1962646A (en) | 2007-05-16 |
CN100427473C true CN100427473C (en) | 2008-10-22 |
Family
ID=38081892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101547228A Expired - Fee Related CN100427473C (en) | 2006-11-21 | 2006-11-21 | Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100427473C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020135569A1 (en) * | 2018-12-26 | 2020-07-02 | 中国人民解放军军事科学院军事医学研究院 | Ethylenediamine compound and use thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419272A (en) * | 1981-02-28 | 1983-12-06 | Degussa Ag | Catalysts for the production of 2-cyanopyrazine |
EP0253360A2 (en) * | 1986-07-15 | 1988-01-20 | Koei Chemical Co., Ltd. | Process for preparing nitriles |
CN1398856A (en) * | 2001-07-20 | 2003-02-26 | 中国石油化工股份有限公司 | Fluidized bed catalyst for preparing 2-cyano pyrazine |
CN1398855A (en) * | 2001-07-20 | 2003-02-26 | 中国石油化工股份有限公司 | Ammoxidation process of preparing 2-cyano pyrazine |
CN1408711A (en) * | 2002-09-24 | 2003-04-09 | 天津大学 | Catalyst for synthesizing 2-cyano pyrazine from 2-methy/pyrazine and synthesizing method |
CN1429820A (en) * | 2003-01-15 | 2003-07-16 | 邯郸市赵都精细化工厂 | Method for preparing 2-cyanopyrazine by ammoxidation method and special catalyst |
JP2005289962A (en) * | 2004-04-05 | 2005-10-20 | Ms Jubilant Organosys Ltd | Method for preparing cyanopyrazine |
-
2006
- 2006-11-21 CN CNB2006101547228A patent/CN100427473C/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419272A (en) * | 1981-02-28 | 1983-12-06 | Degussa Ag | Catalysts for the production of 2-cyanopyrazine |
EP0253360A2 (en) * | 1986-07-15 | 1988-01-20 | Koei Chemical Co., Ltd. | Process for preparing nitriles |
CN1398856A (en) * | 2001-07-20 | 2003-02-26 | 中国石油化工股份有限公司 | Fluidized bed catalyst for preparing 2-cyano pyrazine |
CN1398855A (en) * | 2001-07-20 | 2003-02-26 | 中国石油化工股份有限公司 | Ammoxidation process of preparing 2-cyano pyrazine |
CN1408711A (en) * | 2002-09-24 | 2003-04-09 | 天津大学 | Catalyst for synthesizing 2-cyano pyrazine from 2-methy/pyrazine and synthesizing method |
CN1429820A (en) * | 2003-01-15 | 2003-07-16 | 邯郸市赵都精细化工厂 | Method for preparing 2-cyanopyrazine by ammoxidation method and special catalyst |
JP2005289962A (en) * | 2004-04-05 | 2005-10-20 | Ms Jubilant Organosys Ltd | Method for preparing cyanopyrazine |
Also Published As
Publication number | Publication date |
---|---|
CN1962646A (en) | 2007-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102898264B (en) | Catalytic preparation process for aromatic nitrile or heteroaromatic nitrile | |
CN104628548A (en) | Method for preparing acetophenone by bionic catalytic oxidation of ethylbenzene | |
SA515360954B1 (en) | Process for preparing EDA using SO2-free hydrocyanic acid | |
CN101912779B (en) | Catalyst for catalytic synthesis of N-methylpyrrolidine and application thereof | |
CN104557564B (en) | Preparation method of phenylmethylamine | |
CN104387340B (en) | A kind of method for preparing N methyl piperazines and its catalyst | |
CN100427473C (en) | Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide | |
Saha et al. | Recent advancements of replacing existing aniline production process with environmentally friendly one-pot process: An overview | |
CN101445459A (en) | Method for synthesizing 2, 4-dichloroaniline | |
Ghosh et al. | Hybrid cobalt doped-cerium oxide as a multifunctional nanocatalyst for various organic transformations | |
García-Lacuna et al. | A catalytic scalable Pauson–Khand reaction in a plug flow reactor | |
CN100506377C (en) | Fluidized bed catalyst for ammoxidating propylene to produce acrylonitrile | |
CN100484925C (en) | Preparation process of intermediate 2-cyanpyrazine of pyrazinamide drug | |
CN111732612A (en) | Iron complex containing diphospho-m-carborane ligand and preparation method and application thereof | |
CN108191814B (en) | Method for synthesizing cyclohexanone ethylene ketal under catalysis of titanium ammonium phosphotungstate composite salt | |
CN1189462C (en) | Catalyst for synthesizing 2-cyano pyrazine from 2-methy/pyrazine and synthesizing method | |
CN109748817B (en) | Method for synthesizing aliphatic nitrile from aliphatic aldehyde | |
CN110668972B (en) | Preparation method of 3, 4-dimethoxy benzonitrile | |
CN102746185A (en) | Preparation process of aromatic nitrile compound | |
ES2220098T3 (en) | PROCEDURE FOR OBTAINING ALFA-OMEGA-ALIFATIC DIAMINES. | |
CN104525240A (en) | Application method of ferric nitrate as catalyst in reaction of benzene and hydroxylammonium salt for preparing aniline by one-step-method | |
CN112939811B (en) | Preparation method of aromatic nitrile compound | |
TW467898B (en) | Process for coproducing a cyclic lactam and a cyclic amine | |
CN100427462C (en) | Process for preparing 2,4-difluoro benzonitril | |
CN100408173C (en) | Acrylonitrile catalyst of containing calcium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081022 Termination date: 20111121 |